About the Company
We do not have any company description for enGene Holdings Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on enGene Holdings Inc.
This enGene Holdings Insider Increased Their Holding In The Last Year
Looking at enGene Holdings Inc.'s (NASDAQ:ENGN ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than ...
enGene Holdings Inc. (ENGN) - Yahoo Finance
enGene Holdings Inc. (Nasdaq: ENGN) or ("enGene" or the "Company"), a clinical-stage genetic medicines company whose non-viral lead program EG-70 is in a pivotal study for BCG-unresponsive non-muscle ...
enGene Holdings Inc. (ENGN) Upgraded to Strong Buy: Here's Why
enGene Holdings Inc. (ENGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ENGNW enGene Holdings Inc. C/WTS 31/10/28 (TO PUR COM)
SEC FilingsThu, Jul. 10 enGene Holdings Inc. C/WTS 31/10/28 (TO PUR COM) (ENGNW) - 4 - Statement of Changes in Beneficial Ownership SEC FilingsThu, Jul. 10 See All SEC Filings » ...
enGene Holdings Inc. (ENGN): Wall Street Analysts Recommend This ...
enGene Holdings Inc. (NASDAQ:ENGN) lead candidate, EG-70, is currently under evaluation in a pivotal study for high-risk non-muscle invasive bladder cancer (NMIBC).
enGene Holdings Stock Dividends | NASDAQ:ENGN | Benzinga
enGene Holdings Inc does not currently pay a dividend or dividend information is unavailable. enGene Holdings Inc last traded ex-dividend on Jul 1, 2015 and the next ex-dividend date is unknown.
enGene Holdings Inc. (ENGN) - Yahoo Finance
enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage genetic medicines company whose non-viral, intravesical lead product candidate, EG-70, is in a pivotal study for ...
enGene Holdings Inc. (ENGNW) - Yahoo Finance
enGene to Participate in Upcoming Investor Conferences BOSTON & MONTREAL, April 29, 2025--enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage, non-viral genetic ...
enGene Holdings Inc. (ENGNW) - Yahoo Finance
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635 (c) (4) BOSTON & MONTREAL, January 31, 2025--enGene Holdings Inc. (Nasdaq: ENGN, "enGene" or the "Company"), a clinical-stage genetic ...
Similar Companies
Loading the latest forecasts...